LANDA KATARZYNA AGATA LANDA

Research site

Poland ul. Zacisze 4/1, 31-156 Cracow, Poland

4 trials recruiting
Crohn's disease · Colitis ulcerative · Partial seizures
Adults and children

About Specializations

LANDA KATARZYNA AGATA LANDA in Cracow, Poland specialises in clinical trials of conditions such as Crohn's disease, Colitis ulcerative, Partial seizures, Seizure, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

ul. Zacisze 4/131-156 CracowPoland

Open in maps ↗

Recruiting now: 4 trials
Conditions studied: 8

More sites in Cracow Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

17 clinical trials

Partial seizures

Recruiting

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:BHV-7000
Sponsor:Biohaven Therapeutics Ltd.

Contact Research Centre

Crohn's disease

Recruiting

Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease

Investigational

Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:MORF-057
Sponsor:Morphic Therapeutic Inc.

Contact Research Centre

Seizure

Recruiting

Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Investigational

Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Alprazolam
Sponsor:UCB Biopharma

Contact Research Centre

Seizure

Recruiting

Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Investigational

Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Alprazolam
Sponsor:UCB Biopharma

Contact Research Centre

Partial seizures

Not yet recruiting

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Investigational

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:BHV-7000
Sponsor:Biohaven Therapeutics Ltd.

Contact Research Centre

Safety and Efficacy of Efimosfermin Alfa vs Placebo in Adults with Alcohol-Related Liver Disease

Not yet recruiting

Investigational

Safety and Efficacy of Efimosfermin Alfa vs Placebo in Adults with Alcohol-Related Liver Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Migraine

Not recruiting

Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

Investigational

Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

Investigational

Poland

Participants:18–64 years
Substances:Lu Ag09222
Sponsor:H. Lundbeck A/S

Contact Research Centre

Colitis ulcerative+1

Not recruiting

Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

InvestigationalNo placebo

Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Duvakitug
Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Contact Research Centre

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis

Investigational

Study on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Vibozilimod
Sponsor:Sun Pharmaceutical Industries Limited

Contact Research Centre

Chronic kidney disease

Not recruiting

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:AstraZeneca AB

Contact Research Centre

Crohn's disease

Not recruiting

Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease

Investigational

Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ozanimod
Sponsor:Celgene International II S.a.r.l.

Contact Research Centre

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rosnilimab
Sponsor:Anaptysbio Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites